Cantharis (Laboratoires Boiron)


Welcome to the PulseAid listing for the Cantharis drug offered from Laboratoires Boiron. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Laboratoires Boiron
NON-PROPRIETARY NAME: LYTTA VESICATORIA
SUBSTANCE NAME: LYTTA VESICATORIA
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1983-03-03
END MARKETING DATE: 0000-00-00


Cantharis HUMAN OTC DRUG Details:

Item DescriptionCantharis from Laboratoires Boiron
LABELER NAME: Laboratoires Boiron
DEA SCHEDULE:
ACTIVE STRENGTH: 30([hp_X]/1)
START MARKETING DATE: 1983-03-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0220-1145_6fb3d6f0-7a53-11e6-8c38-424c58303031
PRODUCT NDC: 0220-1145
APPLICATION NUMBER:

Other LYTTA VESICATORIA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BrandStorm HBCCantharis 30c
HOMEOLAB USA INCCANTHARIS
Hyland’sCANTHARIS
Laboratoires BoironCantharis
Natural Health SupplyBladder Irritation
Paramesh Banerji Life Sciences LLCCantharis 200C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncCANTHARIS
Seroyal USACANTHARIS
STANDARD HOMEOPATHIC COMPANYCANTHARIS
Washington Homeopathic ProductsCantharis